Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 26, 2013
Cardiac pacing device also features technology to help identify patients with severe sleep apnea.
-
Jun 25, 2013
New family of pacemakers monitor respiration, adjust pacing accordingly, and support insight into the patient’s overall heart failure status.
-
Jun 24, 2013
Outcomes follow recent NICE guidance supporting safety and effectiveness of subcutaneous implantable defibrillators.
-
Jun 18, 2013
VANTAGE study interim data presented at International Congress of Parkinson's Disease and Movement Disorders in Sydney.
-
Jun 17, 2013First Implant of Company's Vercise Deep Brain Stimulation Device Designed to Treat Parkinson's
Boston Scientific Corporation (NYSE: BSX) announces the first implantation of its Vercise™ DBS System as part of the INTREPID clinical trial. ...
-
Jun 3, 2013
Company continues to demonstrate its commitment to women's health with a research and education grant of more than $1 million for the SUPeR clinical trial.
-
May 27, 2013
GUIDE DBS is the world's first Deep Brain Stimulation visual simulation system.
-
May 24, 2013
Boston Scientific will participate in the healthcare conference on May 30 in Boston. Learn how to watch the webcast or replay.
-
May 22, 2013
Interim data from REDUCE-HTN clinical program presented today at EuroPCR
-
May 22, 2013
New data presented in late-breaking clinical trial session at EuroPCR demonstrated successful deployment of the Lotus™ Valve in the first 60 patients with minimal paravalvular regurgitation at 30 days.